The density of CD11c+CD103+ tolDCs is increased in CeD and these cells can release indoleamine 2,3-dioxygenase (IDO) as a mechanism to induce a tolerogenic state (Matteoli et al., 2010; Welty et al., 2013). Here, ITGAX is linked to cranioectodermal dysplasia.